![](https://static.scientificamerican.com/sciam/cache/file/D866A87E-EA90-4F44-ADAFC8BCEC75D939_agenda.jpg?w=275&h=154&fit=crop)
Why There’s a Serious Cancer Drug Shortage, and How to Fix It
The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market
The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market
The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused
Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations
The nation’s highest court paused a lower court’s decision to nullify approval of the abortion drug mifepristone, keeping the medication available while an appeal moves forward...
The nation’s highest court paused a lower court’s decision to nullify approval of the abortion drug mifepristone, keeping the medication available while an appeal moves forward...
Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial
The world’s best TB drug was too expensive for sufferers—until advocates and a YouTube star changed almost everything
The FDA approved zuranolone, a short-term oral medication that could help new parents who are struggling with depression after giving birth
Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability
The U.S. Food and Drug Administration has approved the use of the oral contraceptive Opill without a prescription, increasing access to birth control at drug stores and online retailers
Ozempic and similar medications may target brain circuitry involved in addiction as well as appetite control
As the threat of antibiotic resistance increases, new antibiotics are imperative—and AI could widen the pipeline
Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now
Manufacturers of a class of food-derived supplements called nutraceuticals often make statements about their health value that are hard to verify, which can cause safety and efficacy issues...
The drug metformin cut long COVID risk by 41 percent in both people who were overweight and those with obesity. But treatments remain elusive
Many generic drugs for cancer and ADHD, blood thinners and antibiotics are in short supply, in part because there is little profit in making them
President Biden is part of a minority of people who have experienced Paxlovid rebound, but experts say the drug should still be prescribed for those who need it
Young children are taking melatonin gummy supplements, but experts say they should be a last resort to help with sleep
Infections of a new strain of Pseudomonas aeruginosa that have led to blindness and death highlight the worsening antibiotic resistance crisis
With an April 7 court decision, one judge has harmed women’s health and undermined trust in science-based drug approvals in the U.S.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account